THURSDAY, Sept. 16, 2021 (HealthDay News) — As severe cases of COVID-19 rise and demand surges for monoclonal antibody treatments, the U.S. government is ordering more from two key suppliers. Monoclonal antibodies, which are lab-engineered immune system proteins, can help trigger a healthy immune response against COVID-19 infection. The BidenContinue Reading

THURSDAY, Sept. 16, 2021 (HealthDay News) — Multiple sclerosis (MS) patients undergoing a treatment that depletes a type of immune cell that fuels MS attacks still have a strong response to mRNA COVID-19 vaccines, a new study finds. “The message from this study is clear — it is worthwhile forContinue Reading

WEDNESDAY, Sept. 15, 2021 (HealthDay News) — It’s hard to resist those big, pleading eyes in the pet store window. But buyer beware. Pet store puppies may infect people with a bacteria for which no common antibiotic treatment exists, a new study warns. Campylobacter jejuni (C jejuni) cannot be treatedContinue Reading

WEDNESDAY, Sept. 15, 2021 (HealthDay News) — When Americans are eligible for Medicare at age 65, they see a significant drop in their out-of-pocket medical costs. Lowering the eligibility age would save even more, especially for people with the highest out-of-pocket costs, according to a new study. “Medicare really improvesContinue Reading

TUESDAY, Sept. 14, 2021 (HealthDay News) – New data out of Israel, to be published this week, could bolster the notion that a third booster shot of the COVID-19 vaccine significantly lowers a recipient’s odds for severe illness. The data is scheduled to be published in the peer-reviewed New EnglandContinue Reading